Epstein O - Search Results

1

Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.

Bairey O, Gabbay U, Blickstein D, Stark P, Prokocimer M, Epstein O, Shaklai M, Lahav J. Bairey O, et al. Among authors: epstein o. Hematol Oncol. 1997 Aug;15(3):121-7. doi: 10.1002/(sici)1099-1069(199708)15:3<121::aid-hon606>3.0.co;2-d. Hematol Oncol. 1997. PMID: 9600111

2

Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders.

Inbal A, Epstein O, Blickstein D, Kornbrot N, Brenner B, Martinowitz U. Inbal A, et al. Among authors: epstein o. Blood Coagul Fibrinolysis. 1993 Aug;4(4):599-604. doi: 10.1097/00001721-199308000-00011. Blood Coagul Fibrinolysis. 1993. PMID: 8218857

3

Central venous line thrombosis in children and young adults with thalassemia major.

Finkelstein Y, Yaniv I, Berant M, Zilber R, Garty BZ, Epstein O, Lahav J, Tamary H. Finkelstein Y, et al. Among authors: epstein o. Pediatr Hematol Oncol. 2004 Jul-Aug;21(5):375-81. doi: 10.1080/08880010490457042. Pediatr Hematol Oncol. 2004. PMID: 15205080

4

The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders.

Schoenfeld N, Epstein O, Lahav M, Mamet R, Shaklai M, Atsmon A. Schoenfeld N, et al. Among authors: epstein o. Cancer Lett. 1988 Dec 1;43(1-2):43-8. doi: 10.1016/0304-3835(88)90211-x. Cancer Lett. 1988. PMID: 3203329

5

Increased porphobilinogen deaminase activity in patients with malignant lymphoproliferative diseases. A helpful diagnostic test.

Lahav M, Epstein O, Schoenfeld N, Shaklai M, Atsmon A. Lahav M, et al. Among authors: epstein o. JAMA. 1987 Jan 2;257(1):39-42. JAMA. 1987. PMID: 3783901

6

[Lymphocyte uroporphyrinogen synthase in the diagnosis of lymphoma and its follow-up].

Lahav M, Epstein O, Schoenfeld N, Shaklai M, Atsmon A. Lahav M, et al. Among authors: epstein o. Harefuah. 1985 Mar 1;108(5):243-5. Harefuah. 1985. PMID: 4007683 Hebrew. No abstract available.

7

Evidence of abnormality of lymphocyte uroporphyrinogen synthase in family members of patients with lymphoproliferative diseases.

Lahav M, Epstein O, Schoenfeld N, Nemesh L, Shaklai M, Atsmon A. Lahav M, et al. Among authors: epstein o. Cancer Lett. 1985 Jan;25(3):305-10. doi: 10.1016/s0304-3835(15)30010-0. Cancer Lett. 1985. PMID: 3971346

8

Erythrocyte uroporphyrinogen synthase activity as a possible diagnostic aid in the diagnosis of lymphoproliferative diseases.

Epstein O, Lahav M, Schoenfeld N, Nemesh L, Shaklai M, Atsmon A. Epstein O, et al. Cancer. 1983 Sep 1;52(5):828-32. doi: 10.1002/1097-0142(19830901)52:5<828::aid-cncr2820520514>3.0.co;2-g. Cancer. 1983. PMID: 6871824

9

Growth rate determines activity of porphobilinogen deaminase both in nonmalignant and malignant cell lines.

Schoenfeld N, Mamet R, Leibovici L, Epstein O, Teitz Y, Atsmon A. Schoenfeld N, et al. Among authors: epstein o. Biochem Med Metab Biol. 1988 Oct;40(2):213-7. doi: 10.1016/0885-4505(88)90121-1. Biochem Med Metab Biol. 1988. PMID: 3190926

10

The heme biosynthetic pathway in the regenerating rat liver. The relation between enzymes of heme synthesis and growth.

Schoenfeld N, Mamet R, Epstein O, Lahav M, Lurie Y, Atsmon A. Schoenfeld N, et al. Among authors: epstein o. Eur J Biochem. 1987 Aug 3;166(3):663-6. doi: 10.1111/j.1432-1033.1987.tb13564.x. Eur J Biochem. 1987. PMID: 2886336 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters